These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9663617)

  • 1. The importance of preventing hepatitis C virus infection among injection drug users in the United States.
    Alter MJ; Moyer LA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S6-10. PubMed ID: 9663617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hepatitis C in the United States.
    Williams I
    Am J Med; 1999 Dec; 107(6B):2S-9S. PubMed ID: 10653448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update.
    Smith BD; Jorgensen C; Zibbell JE; Beckett GA
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S49-53. PubMed ID: 22715214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
    Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
    BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of hepatitis C virus infection.
    Alter MJ
    World J Gastroenterol; 2007 May; 13(17):2436-41. PubMed ID: 17552026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of hepatitis C virus infections among injection drug users.
    Thomas DL; Vlahov D; Solomon L; Cohn S; Taylor E; Garfein R; Nelson KE
    Medicine (Baltimore); 1995 Jul; 74(4):212-20. PubMed ID: 7623656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs - United States, 2015-2016.
    Campbell CA; Canary L; Smith N; Teshale E; Ryerson AB; Ward JW
    MMWR Morb Mortal Wkly Rep; 2017 May; 66(18):465-469. PubMed ID: 28493854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus prevention, care, and treatment: from policy to practice.
    Ward JW; Valdiserri RO; Koh HK
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S58-63. PubMed ID: 22715216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.
    Armstrong GL; Wasley A; Simard EP; McQuillan GM; Kuhnert WL; Alter MJ
    Ann Intern Med; 2006 May; 144(10):705-14. PubMed ID: 16702586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global epidemiology of hepatitis C virus infection.
    Shepard CW; Finelli L; Alter MJ
    Lancet Infect Dis; 2005 Sep; 5(9):558-67. PubMed ID: 16122679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.
    Puzhko S; Roy É; Jutras-Aswad D; Artenie AA; Fortier E; Zang G; Bruneau J
    Int J Drug Policy; 2017 Sep; 47():61-68. PubMed ID: 28666636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal.
    Roy E; Nonn E; Haley N; Cox J
    Int J Drug Policy; 2007 Oct; 18(5):397-405. PubMed ID: 17854728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients.
    Patel PR; Thompson ND; Kallen AJ; Arduino MJ
    Am J Kidney Dis; 2010 Aug; 56(2):371-8. PubMed ID: 20570422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C, illicit drug use and public health: does Canada really have a viable plan?
    Fischer B; Kalousek K; Rehm J; Powis J; Krajden M; Reimer J
    Can J Public Health; 2006; 97(6):485-8. PubMed ID: 17203734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
    Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
    Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.